|
YOKNEAM, Israel and TORONTO, Canada, August 11, 2004 — Syneron Medical Ltd. (Nasdaq: ELOS) announced today the closing of its previously announced initial public offering of 5,000,000 of its ordinary shares at $12.00 per share. Syneron’s ordinary shares are listed on Nasdaq National Market under the symbol "ELOS" and began trading on August 6, 2004.
Syneron has granted the underwriters a 30-day option to purchase an additional 750,000 ordinary shares to cover any over-allotments. Citigroup Global Markets Inc. is acting as sole book-running manager, and CIBC World Markets and Stephens Inc. are acting as co-managers. The ordinary shares are being offered only by prospectus. Copies of the prospectus relating to this offering may be obtained from Citigroup Global Markets at Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220, telephone: (718) 765-6732; facsimile: (718) 765-6734.
A registration statement relating to these securities was filed and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state or other jurisdiction.
|